Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miyo Kudo"'
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:1825-1831
Endothelial dysfunction contributes to cardiometabolic disorders, including hypertension, obesity, and type 2 diabetes. Esaxerenone is a selective, nonsteroidal, high-affinity mineralocorticoid receptor blocker recently approved in Japan for the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbaf543dbd1c91793319768dac1ebfa
https://doi.org/10.1248/bpb.b22-00616
https://doi.org/10.1248/bpb.b22-00616
Publikováno v:
European Journal of Pharmacology. 933:175259
Although methylglyoxal (MGO), a highly reactive dicarbonyl compound, influences the functioning of the vasculature, modulating its effects on vascular reactivity to various substances remains unclear, especially purinoceptor ligands. Therefore, we so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6b3bab7a4b1faacbdc55c7989c89b0
https://doi.org/10.1016/j.ejphar.2022.175259
https://doi.org/10.1016/j.ejphar.2022.175259
Autor:
Takayuki Matsumoto, Madoka Yoshioka, Akane Nogami, Miyo Kudo, Tomoe Osada, Haruka Ogasawara, Natsume Taguchi, Sayaka Endo, Keigo Nakamura, Aiko Yamada, Kumiko Taguchi, Tsuneo Kobayashi
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 96:3-B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8efce9e7e48fc23d11e9b50ba8c03e08
https://doi.org/10.1254/jpssuppl.96.0_3-b-o08-4
https://doi.org/10.1254/jpssuppl.96.0_3-b-o08-4
Publikováno v:
Diabetes Week; 10/9/2023, p611-611, 1p